Sr. DR-TB TB-HIV Supervisor

National TB Elimination Programme (NTEP) and National AIDS Control Programme (NACP) conduct regular review meetings on HIV TB collaborative activities at national and state levels.

At National level 

National level review meeting is held jointly by National AIDS Control Organisation (NACO) and Central TB Division (CTD) and representatives from CTD or NACO jointly review the HIV TB activities. 

At State level

Performance indicators for TB HIV collaborative activities can be grouped under four headings.

• Indicators for state and district level coordination
• Indicators for Intensified case finding
• Indicators for Isoniazid Preventive Treatment (IPT)
• Indicators for HIV testing of TB patients and HIV care, support and treatment

Indicators for State and District Level Coordination

The quarterly report on HIV/TB collaborative activities helps to monitor and assess the performance of HIV-TB collaborative activities.

The report will give an insight to:

Ni-kshay HIV status report is available in the comorbidity reports (Figure 1) which are listed under summary reports (patient management) of Ni-kshay.

The reports are available at the TB Unit (TU), District and State levels.

The report gives a summary (Figure 2) of: 

Alongside regular monitoring through Ni-kshay application, National TB Elimination Programme (NTEP) also recommends conducting periodic meetings at various levels across the country to review the Programmatic Management of Drug-resistant Tuberculosis (PMDT).

These meetings help the programme through discussions and reviews of various aspects such as updates on guidelines, performance tracking, and taking corrective actions in order to address the implementation challenges wherever required.

Under the National TB Elimination Programme (NTEP), as an integral part of the Programmatic Management of Drug-resistant TB (PMDT), the aDSM treatment initiation form is to be filled by the staff at the health facility during the treatment initiation of all DR-TB patients.

This form is available as annexure 32 in the PMDT guidelines 2021 and covers the following information:

The aDSM treatment review form is a schedule to be filled out:

i) When any adverse event is reported by a patient on a newer drug containing a DR-TB regimen 

A Reconstitution Register (RR), as the name suggests, is a register used to record the details of drug boxes reconstituted from the leftover/ remaining/ unused drug boxes of patients who have defaulted, died, failed treatment, or transferred out. 

This register in the format shown below (Figure) is maintained at all the District Tuberculosis Centres (DTCs).

Intensified Case Finding (ICF) in TB-HIV Collaboration